Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Colombat

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomasP Colombat, N C Gorin, M P Lemonnier, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Leukemia & Lymphoma|August 28, 1998
CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 casesG Cartron, C Linassier, J L Bremond, et al.
The New England Journal of Medicine|June 11, 1987
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomaT Philip, J O Armitage, G Spitzer, et al.
Bone Marrow Transplantation|July 23, 1998
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot studyP Moreau, N Milpied, L Voillat, et al.
Bone Marrow Transplantation|July 5, 2011
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trialA Brion, B Mahé, B Kolb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myelomaP Moreau, D Fiere, W R Bezwoda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Leukemia & Lymphoma|January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's diseaseJ Fleury, M Legros, P Colombat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomasP Colombat, N C Gorin, M P Lemonnier, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Leukemia & Lymphoma|August 28, 1998
CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 casesG Cartron, C Linassier, J L Bremond, et al.
The New England Journal of Medicine|June 11, 1987
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomaT Philip, J O Armitage, G Spitzer, et al.
Bone Marrow Transplantation|July 23, 1998
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot studyP Moreau, N Milpied, L Voillat, et al.
Bone Marrow Transplantation|July 5, 2011
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trialA Brion, B Mahé, B Kolb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myelomaP Moreau, D Fiere, W R Bezwoda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Leukemia & Lymphoma|January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's diseaseJ Fleury, M Legros, P Colombat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Pageof 12